NURS 251 Pharmacology | Module 4 Examination Portage Learning 2026/2027 - Actual Q&A with Rationales
NURS 251
Pharmacology
Module 4 Examination
Pain Management & Anesthetic Pharmacology
Actual Questions & Answers with Rationales
Portage Learning (2026/2027) — Updated PDF
90
Total Questions 7
Sections 70%
Scenario-Based 100%
Verified Answers
Cognitive Level Distribution
35% Recall | 45% Application | 20% Analysis
Course Alignment: Portage Learning NURS 251 Pharmacology Module 4
Content Domain: Pain physiology, opioids, NSAIDs, adjuvants, migraine, anesthesia
Rationale Standard: Verified analgesic pharmacology with nursing application
Format: Multiple choice (A-D), ONE correct, with detailed rationales
NURS 251 Module 4 | Updated PDF - Verified Answer Key Page 1
,NURS 251 Pharmacology | Module 4 Examination Portage Learning 2026/2027 - Actual Q&A with Rationales
About This Exam
This comprehensive examination is designed for NURS 251 Pharmacology Module 4 at Portage Learning,
aligned with the 2026/2027 academic cycle. It evaluates mastery of pain management and anesthetic
pharmacology through 90 multiple-choice questions distributed across seven integrated sections. Topics span
pain physiology and nociception, opioid and non-opioid analgesics, adjuvant analgesics, local and general
anesthetics, migraine pharmacotherapy, neuromuscular blockade, and pain management safety and monitoring.
The exam reflects current pharmacology curriculum standards and emphasizes the integration of drug
mechanisms, adverse effects, therapeutic monitoring, and patient safety principles.
Each question includes four options (A-D) with exactly one correct answer. The correct option is marked with the
[CORRECT] tag, followed by a "Correct Answer" line and a 2-4 sentence rationale. Rationales explain why the
correct option is right AND why distractors are wrong, including mechanism of action, adverse effects,
therapeutic monitoring, nursing considerations, and patient safety principles. Use this exam for self-assessment,
targeted review, and competency validation for the Module 4 examination.
How to Use This Exam
Work through each question independently, then review the rationale to identify knowledge gaps and reinforce
understanding. The 70% scenario-based format reflects the application emphasis of pharmacology practice.
Special focus areas include: equianalgesic dosing conversions (Section 2), acetaminophen and NSAID safety
(Section 3), local anesthetic toxicity (Section 4), migraine drug contraindications (Section 5), malignant
hyperthermia recognition (Section 6), and opioid safety and PCA monitoring (Section 7). All answers are verified
for 100% accuracy against current pharmacology references.
Exam Structure
# Topic Questions Items
1 Pain Physiology and Analgesic Foundations Q1-Q12 12
2 Opioid Analgesics Q13-Q30 18
3 Non-Opioid Analgesics and NSAIDs Q31-Q48 18
4 Adjuvant Analgesics and Anesthetics Q49-Q62 14
5 Migraine and Headache Pharmacotherapy Q63-Q72 10
6 Anesthesia and Neuromuscular Blockade Q73-Q82 10
7 Pain Management Safety and Monitoring Q83-Q90 8
Tot
All Sections Q1-Q90 90
al
NURS 251 Module 4 | Updated PDF - Verified Answer Key Page 2
,NURS 251 Pharmacology | Module 4 Examination Portage Learning 2026/2027 - Actual Q&A with Rationales
Section 1: Pain Physiology and Analgesic Foundations
Nociception, Pain Pathways, & Analgesic Principles (Q1-Q12) | 12 Questions
Competency: Describe the four processes of nociception (transduction, transmission, perception, modulation); classify
pain (acute, chronic, nociceptive, neuropathic, cancer); apply the WHO analgesic ladder and multimodal analgesia
principles.
Q1: A nursing student is explaining the nociceptive process to a peer. Which is the CORRECT sequence of
the four processes of nociception?
A. Perception → Transduction → Modulation → Transmission
B. Transduction → Transmission → Perception → Modulation [CORRECT]
C. Transmission → Perception → Modulation → Transduction
D. Modulation → Transduction → Transmission → Perception
Correct Answer: B
Rationale:
Nociception proceeds in the sequence: (1) Transduction (conversion of noxious stimulus to electrical impulse at
nociceptor); (2) Transmission (impulse travels via A-delta and C fibers to dorsal horn, spinothalamic tract, and cortex);
(3) Perception (conscious awareness and interpretation of pain in the brain); (4) Modulation (descending and ascending
pathways that inhibit or amplify pain signals). Understanding these steps guides drug selection: NSAIDs affect
transduction; opioids and local anesthetics affect transmission and modulation; TCAs and gabapentinoids affect
modulation.
Q2: A patient describes their pain as 'sharp, aching, and throbbing' following an orthopedic surgery. This
type of pain is BEST classified as:
A. Neuropathic pain
B. Nociceptive (somatic) pain [CORRECT]
C. Neuropathic visceral pain
D. Central sensitization pain
Correct Answer: B
Rationale:
Sharp, aching, throbbing pain from a surgical site (skin, bone, muscle) is nociceptive SOMATIC pain, caused by
activation of nociceptors in somatic tissues. Neuropathic pain (A, C) is from nerve injury and is typically described as
burning, shooting, electric, or tingling. Visceral pain is from internal organs and is described as cramping, pressure, or
dull. Central sensitization is a chronic pain amplification phenomenon.
NURS 251 Module 4 | Updated PDF - Verified Answer Key Page 3
, NURS 251 Pharmacology | Module 4 Examination Portage Learning 2026/2027 - Actual Q&A with Rationales
Q3: A patient with diabetic neuropathy describes foot pain as 'burning, tingling, and electric shocks.' This
pain is BEST classified as:
A. Nociceptive somatic pain
B. Neuropathic pain [CORRECT]
C. Visceral nociceptive pain
D. Acute pain
Correct Answer: B
Rationale:
Burning, tingling, electric shock descriptions in a patient with diabetic neuropathy are classic for NEUROPATHIC pain
caused by nerve injury/dysfunction. Neuropathic pain responds poorly to traditional opioids and NSAIDs; it is best
treated with adjuvant analgesics (gabapentin, pregabalin, TCAs, SNRIs). Choice A and C are nociceptive (tissue injury);
Choice D is incorrect because diabetic neuropathy is chronic, not acute.
Q4: Which statement BEST describes the difference between acute and chronic pain?
A. Acute pain lasts more than 6 months; chronic pain resolves within hours
B. Acute pain has a predictable duration (typically <3-6 months) and serves a protective function; chronic
pain persists beyond expected healing time (often >3 months) and serves no adaptive purpose
[CORRECT]
C. Acute pain is always mild; chronic pain is always severe
D. Acute pain requires opioids; chronic pain requires only NSAIDs
Correct Answer: B
Rationale:
Acute pain has a predictable, limited duration (typically <3-6 months) tied to tissue injury and serves a protective
biological function (e.g., withdrawal, immobilization). Chronic pain persists beyond the expected healing time (often
defined as >3 months) and serves no adaptive purpose; it can lead to depression, anxiety, sleep disturbance, and
disability. Both can be mild or severe; medication selection is based on etiology and severity, not duration alone.
Q5: According to the WHO Three-Step Analgesic Ladder, a patient with MODERATE cancer pain not
relieved by non-opioids should advance to which step?
A. Step 1: Non-opioid ± adjuvant
B. Step 2: Opioid for mild-to-moderate pain (e.g., codeine, hydrocodone) ± non-opioid ± adjuvant
[CORRECT]
C. Step 3: Opioid for moderate-to-severe pain (e.g., morphine, fentanyl) ± non-opioid ± adjuvant
D. Step 4: Neuromuscular blockade
Correct Answer: B
Rationale:
WHO Step 2 is for mild-to-moderate pain not relieved by Step 1 non-opioids: use a 'weak' opioid (codeine, hydrocodone,
tramadol) ± non-opioid (acetaminophen/NSAID) ± adjuvant. Step 3 is for moderate-to-severe pain: use a 'strong' opioid
(morphine, fentanyl, hydromorphone, oxycodone). Choice A is Step 1; Choice C is Step 3 (skipping Step 2); Choice D is
not part of the WHO ladder.
NURS 251 Module 4 | Updated PDF - Verified Answer Key Page 4
NURS 251
Pharmacology
Module 4 Examination
Pain Management & Anesthetic Pharmacology
Actual Questions & Answers with Rationales
Portage Learning (2026/2027) — Updated PDF
90
Total Questions 7
Sections 70%
Scenario-Based 100%
Verified Answers
Cognitive Level Distribution
35% Recall | 45% Application | 20% Analysis
Course Alignment: Portage Learning NURS 251 Pharmacology Module 4
Content Domain: Pain physiology, opioids, NSAIDs, adjuvants, migraine, anesthesia
Rationale Standard: Verified analgesic pharmacology with nursing application
Format: Multiple choice (A-D), ONE correct, with detailed rationales
NURS 251 Module 4 | Updated PDF - Verified Answer Key Page 1
,NURS 251 Pharmacology | Module 4 Examination Portage Learning 2026/2027 - Actual Q&A with Rationales
About This Exam
This comprehensive examination is designed for NURS 251 Pharmacology Module 4 at Portage Learning,
aligned with the 2026/2027 academic cycle. It evaluates mastery of pain management and anesthetic
pharmacology through 90 multiple-choice questions distributed across seven integrated sections. Topics span
pain physiology and nociception, opioid and non-opioid analgesics, adjuvant analgesics, local and general
anesthetics, migraine pharmacotherapy, neuromuscular blockade, and pain management safety and monitoring.
The exam reflects current pharmacology curriculum standards and emphasizes the integration of drug
mechanisms, adverse effects, therapeutic monitoring, and patient safety principles.
Each question includes four options (A-D) with exactly one correct answer. The correct option is marked with the
[CORRECT] tag, followed by a "Correct Answer" line and a 2-4 sentence rationale. Rationales explain why the
correct option is right AND why distractors are wrong, including mechanism of action, adverse effects,
therapeutic monitoring, nursing considerations, and patient safety principles. Use this exam for self-assessment,
targeted review, and competency validation for the Module 4 examination.
How to Use This Exam
Work through each question independently, then review the rationale to identify knowledge gaps and reinforce
understanding. The 70% scenario-based format reflects the application emphasis of pharmacology practice.
Special focus areas include: equianalgesic dosing conversions (Section 2), acetaminophen and NSAID safety
(Section 3), local anesthetic toxicity (Section 4), migraine drug contraindications (Section 5), malignant
hyperthermia recognition (Section 6), and opioid safety and PCA monitoring (Section 7). All answers are verified
for 100% accuracy against current pharmacology references.
Exam Structure
# Topic Questions Items
1 Pain Physiology and Analgesic Foundations Q1-Q12 12
2 Opioid Analgesics Q13-Q30 18
3 Non-Opioid Analgesics and NSAIDs Q31-Q48 18
4 Adjuvant Analgesics and Anesthetics Q49-Q62 14
5 Migraine and Headache Pharmacotherapy Q63-Q72 10
6 Anesthesia and Neuromuscular Blockade Q73-Q82 10
7 Pain Management Safety and Monitoring Q83-Q90 8
Tot
All Sections Q1-Q90 90
al
NURS 251 Module 4 | Updated PDF - Verified Answer Key Page 2
,NURS 251 Pharmacology | Module 4 Examination Portage Learning 2026/2027 - Actual Q&A with Rationales
Section 1: Pain Physiology and Analgesic Foundations
Nociception, Pain Pathways, & Analgesic Principles (Q1-Q12) | 12 Questions
Competency: Describe the four processes of nociception (transduction, transmission, perception, modulation); classify
pain (acute, chronic, nociceptive, neuropathic, cancer); apply the WHO analgesic ladder and multimodal analgesia
principles.
Q1: A nursing student is explaining the nociceptive process to a peer. Which is the CORRECT sequence of
the four processes of nociception?
A. Perception → Transduction → Modulation → Transmission
B. Transduction → Transmission → Perception → Modulation [CORRECT]
C. Transmission → Perception → Modulation → Transduction
D. Modulation → Transduction → Transmission → Perception
Correct Answer: B
Rationale:
Nociception proceeds in the sequence: (1) Transduction (conversion of noxious stimulus to electrical impulse at
nociceptor); (2) Transmission (impulse travels via A-delta and C fibers to dorsal horn, spinothalamic tract, and cortex);
(3) Perception (conscious awareness and interpretation of pain in the brain); (4) Modulation (descending and ascending
pathways that inhibit or amplify pain signals). Understanding these steps guides drug selection: NSAIDs affect
transduction; opioids and local anesthetics affect transmission and modulation; TCAs and gabapentinoids affect
modulation.
Q2: A patient describes their pain as 'sharp, aching, and throbbing' following an orthopedic surgery. This
type of pain is BEST classified as:
A. Neuropathic pain
B. Nociceptive (somatic) pain [CORRECT]
C. Neuropathic visceral pain
D. Central sensitization pain
Correct Answer: B
Rationale:
Sharp, aching, throbbing pain from a surgical site (skin, bone, muscle) is nociceptive SOMATIC pain, caused by
activation of nociceptors in somatic tissues. Neuropathic pain (A, C) is from nerve injury and is typically described as
burning, shooting, electric, or tingling. Visceral pain is from internal organs and is described as cramping, pressure, or
dull. Central sensitization is a chronic pain amplification phenomenon.
NURS 251 Module 4 | Updated PDF - Verified Answer Key Page 3
, NURS 251 Pharmacology | Module 4 Examination Portage Learning 2026/2027 - Actual Q&A with Rationales
Q3: A patient with diabetic neuropathy describes foot pain as 'burning, tingling, and electric shocks.' This
pain is BEST classified as:
A. Nociceptive somatic pain
B. Neuropathic pain [CORRECT]
C. Visceral nociceptive pain
D. Acute pain
Correct Answer: B
Rationale:
Burning, tingling, electric shock descriptions in a patient with diabetic neuropathy are classic for NEUROPATHIC pain
caused by nerve injury/dysfunction. Neuropathic pain responds poorly to traditional opioids and NSAIDs; it is best
treated with adjuvant analgesics (gabapentin, pregabalin, TCAs, SNRIs). Choice A and C are nociceptive (tissue injury);
Choice D is incorrect because diabetic neuropathy is chronic, not acute.
Q4: Which statement BEST describes the difference between acute and chronic pain?
A. Acute pain lasts more than 6 months; chronic pain resolves within hours
B. Acute pain has a predictable duration (typically <3-6 months) and serves a protective function; chronic
pain persists beyond expected healing time (often >3 months) and serves no adaptive purpose
[CORRECT]
C. Acute pain is always mild; chronic pain is always severe
D. Acute pain requires opioids; chronic pain requires only NSAIDs
Correct Answer: B
Rationale:
Acute pain has a predictable, limited duration (typically <3-6 months) tied to tissue injury and serves a protective
biological function (e.g., withdrawal, immobilization). Chronic pain persists beyond the expected healing time (often
defined as >3 months) and serves no adaptive purpose; it can lead to depression, anxiety, sleep disturbance, and
disability. Both can be mild or severe; medication selection is based on etiology and severity, not duration alone.
Q5: According to the WHO Three-Step Analgesic Ladder, a patient with MODERATE cancer pain not
relieved by non-opioids should advance to which step?
A. Step 1: Non-opioid ± adjuvant
B. Step 2: Opioid for mild-to-moderate pain (e.g., codeine, hydrocodone) ± non-opioid ± adjuvant
[CORRECT]
C. Step 3: Opioid for moderate-to-severe pain (e.g., morphine, fentanyl) ± non-opioid ± adjuvant
D. Step 4: Neuromuscular blockade
Correct Answer: B
Rationale:
WHO Step 2 is for mild-to-moderate pain not relieved by Step 1 non-opioids: use a 'weak' opioid (codeine, hydrocodone,
tramadol) ± non-opioid (acetaminophen/NSAID) ± adjuvant. Step 3 is for moderate-to-severe pain: use a 'strong' opioid
(morphine, fentanyl, hydromorphone, oxycodone). Choice A is Step 1; Choice C is Step 3 (skipping Step 2); Choice D is
not part of the WHO ladder.
NURS 251 Module 4 | Updated PDF - Verified Answer Key Page 4
